Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Recruiting 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Leukemia 103Leukemia, Myeloid, Acute 93Myelodysplastic Syndromes 84Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma, Non-Hodgkin 58Multiple Myeloma 57Hodgkin Disease 52Leukemia, Lymphocytic, Chronic, B-Cell 49Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 42Lymphoma, Large B-Cell, Diffuse 40Neoplasms, Plasma Cell 39Lymphoma, Follicular 39Myeloproliferative Disorders 38Leukemia, Myelomonocytic, Chronic 37Leukemia, Myeloid, Accelerated Phase 37Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 33Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 33Blast Crisis 32Anemia, Refractory, with Excess of Blasts 31Primary Myelofibrosis 28Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Dendritic Cell Sarcoma, Interdigitating 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 20

Interventions

Vincristine 3Topotecan 3Stem Cell Transplantation 3Radiation 3Platinum 3Melphalan 3Doxorubicin 3Cyclophosphamide 3Congresses as Topic 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3sargramostim 2dinutuximab 2Isotretinoin 2Etoposide 2Colony-Stimulating Factors 2Busulfan 2temsirolimus 1etoposide phosphate 1Thiotepa 1Temozolomide 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Ganglioneuroblastoma × Busulfan × Clear all
NCT01175356 2026-01-23

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Children's Oncology Group

Phase 1 Completed
99 enrolled 11 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT01798004 2024-07-15

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Children's Oncology Group

Phase 1 Completed
150 enrolled 9 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡